SHERRY KROPATSCH: Open Payments
NPI 1851762785 · GRAND ISLAND, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,083 in 124 payments from 15 companies in 2025. Trend: 2023 $1,982 · 2024 $2,002 · 2025 $2,083
Food & beverage: $2,083
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 30 | $373 |
| ABBVIE INC. | 32 | $309 |
| E.R. Squibb & Sons, L.L.C. | 14 | $255 |
| Alkermes, Inc. | 9 | $208 |
| Axsome Therapeutics, Inc. | 5 | $184 |
| Collegium Pharmaceutical, Inc. | 7 | $137 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $109 |
| Janssen Pharmaceuticals, Inc | 5 | $105 |
| Neurocrine BioSciences, Inc. | 4 | $101 |
| Supernus Pharmaceuticals, Inc. | 3 | $75 |
Products named: VRAYLAR, COBENFY, REXULTI, ARISTADA, Auvelity, ABILIFY MAINTENA, Jornay PM, CAPLYTA.
Industry payments across NE — which companies pay providers there.
